1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About ICU Medical, Inc.

ICU Medical, Inc. develops, manufactures and sells innovative medical products used in infusion therapy and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. ICU Medical is headquartered in San Clemente, California.
Vivek Jain

951 Calle Amanecer
San Clemente, California 92673-6212
Phone: 19493662183


What''s Driving ICU Medical Inc''s Surprising 15% Stock Rally?
Jun 17, 2024 15:11pm

What''s Driving ICU Medical Inc''s Surprising 15% Stock Rally?

Raymond James upgrades ICU Medical stock, highlights growth prospects
Jun 17, 2024 09:30am
ICU Medical Inc Struggles in First Quarter of 2024, Investors Concerned
May 08, 2024 20:37pm

Investors in ICU Medical Inc may be concerned after the company reported losses in the first quarter of 2024 due to deteriorating demand. The medical equipment and supplies sector as a whole experienced a top-line gain, further highlighting ICU Medical Inc''s underperformance. In the first quarter of 2024, ICU Medical Inc saw a decrease in revenue by -0.423% to $566.24 million, with a loss per share of $-1.63 compared to $-0.41 per share in the same period last year. The company''s net loss also significantly increased to $-39.471 million from $-9.812 million a year ago. Despite these challenges, ICU Medical Inc remains optimistic about its future prospects. The company will be presenting at the KeyBanc Life Sciences & MedTech Investor Forum on March 20, 2024, where management will discuss their strategies for navigating the current market conditions. However, investors should be cautious as ICU Medical Inc''s stock has declined by -46.34% compared to a year ago and is currently trading only 23.6% above its 52-week low.

ICU Medical, Inc. (ICUI) Q1 2024 Earnings Call Transcript
May 08, 2024 02:43am

No summary available.

Source:Seeking Alpha
ICUI Stock Earnings: ICU Medical Beats EPS, Beats Revenue for Q1 2024
May 08, 2024 01:01am

ICU Medical (NASDAQ: ICUI ) just reported results for the first quarter of 2024. ICU Medical reported earnings per share of 96 cents. This was above the analyst estimate for EPS of 82 cents. The company reported revenue of $566.66 million. This was 2.61% better than the analyst estimate for revenue of $552.25 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million.

ICU Medical, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 07, 2024 22:36pm

No summary available.

Source:Seeking Alpha
ICU Medical Q1 Earnings Summary
May 07, 2024 22:15pm

Here are the recent earnings highlights for health The post ICU Medical Q1 Earnings Summary appeared first on ForexTV .

ICU Medical: Q1 Earnings Snapshot
May 07, 2024 20:51pm

SAN CLEMENTE, Calif. (AP) — SAN CLEMENTE, Calif. (AP) — ICU Medical Inc. (ICUI) on Tuesday reported a loss of $39.5 million in its first quarter.

Source:San Mateo Daily Journal
ICU Medical Announces Time of First Quarter 2024 Earnings Conference Call
Apr 23, 2024 12:30pm

SAN CLEMENTE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2024 earnings release and conference call.